510(k) Report

510(k) · Cleared

Cleared

Cirrus HD-Oct

K222200510(k) TraditionalCleared Apr 13, 2023262-day reviewClass II21 CFR 886.1570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Carl Zeiss Meditec, Inc. · OBO Tomography, Optical Coherence

Cleared on Apr 13, 2023 as substantially equivalent to K181534 (Carl Zeiss Meditec, Inc., 2019) after a 262-day review. Its family tree reaches back 10 generations to 2002. 1 later device descends from it.

Decided
Apr 13, 2023
Review
262 days
Class
Class II
Product code
OBO
Recalls
None
Predicates
1

Its longest line of descent runs back 10 generations to K012727 (2002). 26 ancestors in all, the oldest K946058 (1995). 1 later device descends from it, 1 citing it directly.

  1. Root · 10 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
  2. 6 generations between
  3. 3 generations backK150977 Cirrus HD-OctCarl Zeiss Meditec, Inc. · 2015
  4. 2 generations backK161194 PLEX Elite 9000 SS-OCTCarl Zeiss Meditec, Inc. · 2016 · Recalled
  5. 1 generation backK181534 Cirrus HD-OctCarl Zeiss Meditec, Inc. · 2019 · Recalled
  6. This deviceK222200 Cirrus HD-OctCarl Zeiss Meditec, Inc. · 2023
  7. Descendant · cites it directly · 0 of its ownK233933 CIRRUS™ HD-OCT Model 6000Carl Zeiss Meditec, Inc. · 2024
Show all 10 generations
  1. Root · 10 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
  2. 9 generations backK030433 Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc. · 2003 · Recalled
  3. 8 generations backK033123 Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 2004 · Recalled
  4. 7 generations backK063343 Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc. · 2006
  5. 6 generations backK071250 CA, Model: CamOptovue, Inc. · 2007
  6. 5 generations backK101505 Rtvue Model Rtvue 100Optovue, Inc. · 2010 · Recalled
  7. 4 generations backK111157 CIRRUS HD-OCT WITH RETINAL NERVE FIBER LAYER, MACULAR, OPTIC NERVE…Carl Zeiss Meditec, Inc. · 2012
  8. 3 generations backK150977 Cirrus HD-OctCarl Zeiss Meditec, Inc. · 2015
  9. 2 generations backK161194 PLEX Elite 9000 SS-OCTCarl Zeiss Meditec, Inc. · 2016 · Recalled
  10. 1 generation backK181534 Cirrus HD-OctCarl Zeiss Meditec, Inc. · 2019 · Recalled
  11. This deviceK222200 Cirrus HD-OctCarl Zeiss Meditec, Inc. · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K233933CIRRUS™ HD-OCT Model 6000Carl Zeiss Meditec, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K012727Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc.2002—
−9K030433Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc.20031
−8K033123Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc.20041
−7K063343Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc.2006—
−6K071250CA, Model: CamOptovue, Inc.2007—
−5K101505Rtvue Model Rtvue 100Optovue, Inc.20101
−4K111157CIRRUS HD-OCT WITH RETINAL NERVE FIBER LAYER, MACULAR, OPTIC NERVE HEAD, and…Carl Zeiss Meditec, Inc.2012—
−3K150977Cirrus HD-OctCarl Zeiss Meditec, Inc.2015—
−2K161194PLEX Elite 9000 SS-OCTCarl Zeiss Meditec, Inc.20161
−1K181534Cirrus HD-OctCarl Zeiss Meditec, Inc.20192
0 (this device)K222200Cirrus HD-OctCarl Zeiss Meditec, Inc.2023—
+1K233933CIRRUS™ HD-OCT Model 6000Carl Zeiss Meditec, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199520
199810
200110
200220
200310
200420
200510
200630
200710
200910
201010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K222200, 2002–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBO device

  1. #1 K250868 SPECTRALIS HRA+OCT and variantsscore 16.2 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K181534Cirrus HD-Oct
Summary page 5
…Classification: 21CFR886.1570 Optical Coherence Tomography (OCT) Regulatory Class: 1T Product Code: OBO 3. PREDICATE DEVICE Predicate Device: CIRRUS HD-OCT Model 5000 (K181534) Classification: 21CFR886.1570 Optical Coherence Tomography (OCT) Regulatory Class: II Product Code: OBO, IYO, ITX 4. DEVICE DES…
Carl Zeiss Meditec, Inc.20192

Also cleared against K181534: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K233933CIRRUS™ HD-OCT Model 6000Carl Zeiss Meditec, Inc.20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 2.3 years on median.
  • 6 of the 26 ancestors have a recall of any class.
  • Of its descendants, K233933 (Carl Zeiss Meditec, Inc., 2024) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K181534.

How does its category compare?

All OBO devices

OBO Tomography, Optical Coherence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · OBO

3in 2025

2007: 22008: 22009: 42010: 22011: 22012: 32013: 22014: 32015: 12016: 42017: 42018: 62019: 52020: 22021: 12022: 22023: 72024: 82025: 32026 (partial year): 2
2007high 8 (2024) · low 1 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBO

125in 2025

2009: 151 days median2012: 269 days median2014: 152 days median2016: 125 days median2017: 118 days median2018: 87 days median2019: 249 days median2023: 262 days median2024: 157 days median2025: 125 days median
2007high 269 (2012) · low 87 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBO

1in 2022

2010: 12011: 22012: 22018: 12021: 12022: 12026 (partial year): 1
2007high 2 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBO

4in 2025

2013: 22016: 12018: 12021: 12023: 32024: 32025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
2009415100
20102—10
20112—20
2012326920
20132—02
2014315200
20151—00
2016412501
2017411800
201868711
2019524900
20202—00
20211—11
20222—10
2023726203
2024815703
2025312504
20262—1—

What is it indicated for?

CIRRUS™ HD-OCT is a non-contact, high resolution tomographic and biomicroscopic imaging device intended for in vivo viewing, axial cross-sectional, and three-dimensional imaging of anterior and posterior ocular structures. The device is indicated for visualizing and measuring anterior and posterior ocular structures, including cornea, corneal epithelium, retina, retinal nerve fiber layer, ganglion cell plus inner plexiform layer, macula, and optic nerve…

Read the full statement (116 words)

CIRRUS™ HD-OCT is a non-contact, high resolution tomographic and biomicroscopic imaging device intended for in vivo viewing, axial cross-sectional, and three-dimensional imaging of anterior and posterior ocular structures. The device is indicated for visualizing and measuring anterior and posterior ocular structures, including cornea, corneal epithelium, retina, retinal nerve fiber layer, ganglion cell plus inner plexiform layer, macula, and optic nerve head.

CIRRUS’ AngioPlex OCT Angiography is indicated as an aid in the visualization of vascular structures of the retina and choroid.

CIRRUS HD-OCT is indicated as a diagnostic device to aid in the detection and management of ocular diseases including, but not limited to, macular holes, cystoid macular edema, diabetic retinopathy, age-related macular degeneration, and glaucoma.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K222200: Cirrus HD-Oct.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K222200

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026